A novel resistance reversion mechanism in a vancomycin-variable Enterococcus faecium strain

Objectives To investigate an outbreak of Enterococcus faecium in a hospital haematology ward and uncover the mechanism of a vancomycin resistance phenotype-genotype disparity in an isolate from this outbreak. Methods Whole genome shotgun sequencing was used for the phylogenetic analysis of E. faecium isolates (n = 39) and to identify the carriage of antibiotic resistance genes. A long-read sequencing approach was adopted to identify structural variations in the vancomycin resistance region of a vancomycin-variable E. faecium (VVE) and to uncover the resistance reversion mechanism in this isolate. RT-qPCR and RT-PCR were used to determine differences in the expression of vanRS and vanHAX among strains. Results The E. faecium strains isolated in the hospital haematology ward were extensively drug resistant and highly diverse. The notable expansion of ST262 among patients was the likely driver of a VRE outbreak. A VVE isolate was identified that could rapidly revert to a vancomycin-resistant state in the presence of vancomycin. Disruption of the vanR gene in this isolate by an IS6-family element impaired its response to vancomycin. However, when the isolate was evolved to vancomycin resistance, it could constitutively express the vanHAX genes at levels up to 36,000-fold greater than the parent isolate via co-transcription with a ribosomal RNA operon. Conclusion In this study, we report a VVE isolate that was isolated during a VRE outbreak. This strain was capable of rapidly reverting to a resistant phenotype through a novel mechanism involving integration of vanHAX downstream of a ribosomal RNA operon. During VRE outbreaks, attention should be paid to contemporaneous vancomycin-susceptible strains as these may carry silent vancomycin resistance genes that can be activated through genomic rearrangements upon exposure to vancomycin.

[1]  K. Walia,et al.  Detection of vancomycin variable enterococci (VVE) among clinical isolates of Enterococcus faecium collected across India-first report from the subcontinent. , 2022, Indian journal of medical microbiology.

[2]  J. A. Samaniego Castruita,et al.  Genomic analysis of 600 vancomycin-resistant Enterococcus faecium reveals a high prevalence of ST80 and spread of similar vanA regions via IS1216E and plasmid transfer in diverse genetic lineages in Ireland , 2021, The Journal of antimicrobial chemotherapy.

[3]  P. Bork,et al.  Interactive Tree Of Life (iTOL) v5: an online tool for phylogenetic tree display and annotation , 2021, Nucleic Acids Res..

[4]  T. Gray,et al.  Vancomycin variable Enterococcus (VVE), E. faecium, harbouring the vanA gene complex. , 2020, Pathology.

[5]  C. Giske,et al.  Genomic analysis revealed distinct transmission clusters of vancomycin-resistant Enterococcus faecium ST80 in Stockholm, Sweden. , 2020, The Journal of hospital infection.

[6]  R. Kaas,et al.  ResFinder 4.0 for predictions of phenotypes from genotypes , 2020, The Journal of antimicrobial chemotherapy.

[7]  D. Coleman,et al.  A hospital outbreak of linezolid-resistant and vancomycin-resistant ST80 Enterococcus faecium harbouring an optrA-encoding conjugative plasmid investigated by whole-genome sequencing. , 2020, The Journal of hospital infection.

[8]  A. Petersen,et al.  Association between vancomycin-resistant Enterococcus faecium colonization and subsequent infection: a retrospective WGS study. , 2020, The Journal of antimicrobial chemotherapy.

[9]  Christopher Beaudoin,et al.  Producing polished prokaryotic pangenomes with the Panaroo pipeline , 2020, Genome Biology.

[10]  P. Stogios,et al.  Molecular mechanisms of vancomycin resistance , 2020, Protein science : a publication of the Protein Society.

[11]  M. Emaneini,et al.  Antimicrobial resistance pattern, virulence determinants and molecular analysis of Enterococcus faecium isolated from children infections in Iran , 2019, BMC microbiology.

[12]  N. Tucker,et al.  Emergence of an Australian-like pstS-null vancomycin resistant Enterococcus faecium clone in Scotland , 2019, PloS one.

[13]  Keith A Jolley,et al.  Open-access bacterial population genomics: BIGSdb software, the PubMLST.org website and their applications , 2018, Wellcome open research.

[14]  P. Worning,et al.  Emergence of a vancomycin-variable Enterococcus faecium ST1421 strain containing a deletion in vanX , 2018, The Journal of antimicrobial chemotherapy.

[15]  Sergio Arredondo-Alonso,et al.  mlplasmids: a user-friendly tool to predict plasmid- and chromosome-derived sequences for single species , 2018, bioRxiv.

[16]  Samir N. Patel,et al.  Prevalence of vancomycin-variable Enterococcus faecium (VVE) among vanA-positive sterile site isolates and patient factors associated with VVE bacteremia , 2018, PloS one.

[17]  Jia Gu,et al.  fastp: an ultra-fast all-in-one FASTQ preprocessor , 2018, bioRxiv.

[18]  M. Bonten,et al.  RNA-seq and Tn-seq reveal fitness determinants of vancomycin-resistant Enterococcus faecium during growth in human serum , 2017, BMC Genomics.

[19]  Ryan R. Wick,et al.  Unicycler: Resolving bacterial genome assemblies from short and long sequencing reads , 2016, bioRxiv.

[20]  Andreas Wagner,et al.  Growthcurver: an R package for obtaining interpretable metrics from microbial growth curves , 2016, BMC Bioinformatics.

[21]  Daniel J. Wilson,et al.  ClonalFrameML: Efficient Inference of Recombination in Whole Bacterial Genomes , 2015, PLoS Comput. Biol..

[22]  Samir N. Patel,et al.  Vancomycin-Variable Enterococci Can Give Rise to Constitutive Resistance during Antibiotic Therapy , 2014, Antimicrobial Agents and Chemotherapy.

[23]  C. Arias,et al.  Mechanisms of antibiotic resistance in enterococci , 2014, Expert review of anti-infective therapy.

[24]  Torsten Seemann,et al.  Prokka: rapid prokaryotic genome annotation , 2014, Bioinform..

[25]  Samir N. Patel,et al.  Outbreak of Vancomycin-Susceptible Enterococcus faecium Containing the Wild-Type vanA Gene , 2014, Journal of Clinical Microbiology.

[26]  Samir N. Patel,et al.  Vancomycin-Variable Enterococcus faecium: In Vivo Emergence of Vancomycin Resistance in a Vancomycin-Susceptible Isolate , 2014, Journal of Clinical Microbiology.

[27]  M. Huycke,et al.  Enterococcal Disease, Epidemiology, and Implications for Treatment , 2014 .

[28]  Alexandros Stamatakis,et al.  RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies , 2014, Bioinform..

[29]  Allison D. Griggs,et al.  Emergence of Epidemic Multidrug-Resistant Enterococcus faecium from Animal and Commensal Strains , 2013, mBio.

[30]  Ronny Lorenz,et al.  The Vienna RNA Websuite , 2008, Nucleic Acids Res..

[31]  S. Salzberg,et al.  Rapid, accurate, computational discovery of Rho-independent transcription terminators illuminates their relationship to DNA uptake , 2007, Genome Biology.

[32]  R. Gourse,et al.  rRNA transcription in Escherichia coli. , 2004, Annual review of genetics.

[33]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[34]  J. Andrews,et al.  Determination of minimum inhibitory concentrations. , 2001, The Journal of antimicrobial chemotherapy.

[35]  S. Handwerger,et al.  Heterogeneity of the vanA gene cluster in clinical isolates of enterococci from the northeastern United States , 1995, Antimicrobial agents and chemotherapy.

[36]  C. Walsh,et al.  Identification of the DNA-binding site for the phosphorylated VanR protein required for vancomycin resistance in Enterococcus faecium. , 1994, Biochemistry.

[37]  J. Duval,et al.  Characterization of the chromosomal aac(6')-Ii gene specific for Enterococcus faecium , 1993, Antimicrobial Agents and Chemotherapy.

[38]  M. Arthur,et al.  Characterization of Tn1546, a Tn3-related transposon conferring glycopeptide resistance by synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147 , 1993, Journal of bacteriology.

[39]  P. Worning,et al.  Enterococcus faecium ST 1421-CT 1134 clone , Denmark , 2015 to March 2019 , 2019 .

[40]  M. Gilmore,et al.  Enterococcal Disease, Epidemiology, and Implications for Treatment -- Enterococci: From Commensals to Leading Causes of Drug Resistant Infection , 2014 .

[41]  C. Watanakunakorn Mode of action and in-vitro activity of vancomycin. , 1984, The Journal of antimicrobial chemotherapy.